Author:
Xu Feng,Wu Ling-Yun,He Qi,Wu Dong,Zhang Zheng,Song Lu-Xi,Zhao You-Shan,Su Ji-Ying,Zhou Li-Yu,Guo Juan,Chang Chun-Kang,Li Xiao
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Adès, L., Itzykson, R. & Fenaux, P. Myelodysplastic syndromes. Lancet 383, 2239–2252 (2014).
2. Odenike, O., Onida, F. & Padron, E. Myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: an update on risk stratification, molecular genetics, and therapeutic approaches including allogeneic hematopoietic stem cell transplantation. Am Soc Clin Oncol Educ Book, e398–412 (2015).
3. Greenberg, P., Cox, C., LeBeau, M. M. et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89, 2079–2088 (1997).
4. Bejar, R., Stevenson, K., Abdel-Wahab, O. et al. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med 364, 2496–2506 (2011).
5. Bejar, R., Stevenson, K. E., Caughey, B. A. et al. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. J Clin Oncol 30, 3376–3382 (2012).
Cited by
121 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献